GE HealthCare misses Q1 profit estimates, cuts 2026 adj. EPS outlook

GE HealthCare Technologies

29/04/2026 11:32

Overview

US medical technology firm's Q1 revenue rose 7.4%, beating analyst expectations

Adjusted EPS for Q1 missed analyst expectations

Profitability impacted by supplier issue and higher input costs, now resolved

Outlook

GE HealthCare reaffirms 2026 organic revenue growth guidance of 3.0% to 4.0%

Company lowers 2026 adjusted EBIT margin outlook to 15.4%-15.7% from 15.8%-16.1%

GE HealthCare cuts 2026 adjusted EPS guidance to $4.80-$5.00 from $4.95-$5.15

Result Drivers

SEGMENT GROWTH - Revenue growth led by Pharmaceutical Diagnostics, Advanced Visualization Solutions, and Imaging, with strength in U.S., EMEA, and Rest of World

SUPPLIER ISSUE - Profitability was negatively impacted by a discrete Pharmaceutical Diagnostics supplier issue, now resolved

INPUT COST INFLATION - Higher memory chip, oil, and freight costs weighed on profit margins; company expects inflation to continue impacting results

Company press release: ID:nBwbl6KPva

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
Beat
$5.10 bln
$5.04 bln (14 Analysts)
Q1 Adjusted EPS
Miss
$0.99
$1.05 (15 Analysts)
Q1 EPS
$0.85
Q1 Net Income
$389 mln
Q1 Cash flow from operating activities
$290 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 14 "strong buy" or "buy", 7 "hold" and 1 "sell" or "strong sell"

The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"

Wall Street's median 12-month price target for GE Healthcare Technologies Inc is $89.50, about 30.7% above its April 28 closing price of $68.50

The stock recently traded at 13 times the next 12-month earnings vs. a P/E of 17 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)